Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neuroendocrine Tumors | 40 | 2025 | 657 | 7.730 |
Why?
|
Medulloblastoma | 19 | 2022 | 683 | 1.820 |
Why?
|
Pancreatic Neoplasms | 18 | 2023 | 5443 | 1.400 |
Why?
|
Neuroectodermal Tumors, Primitive | 7 | 2023 | 137 | 1.300 |
Why?
|
Cerebellar Neoplasms | 10 | 2022 | 591 | 1.270 |
Why?
|
Brain Neoplasms | 36 | 2024 | 9213 | 1.200 |
Why?
|
Hedgehog Proteins | 12 | 2022 | 771 | 1.060 |
Why?
|
Oligodendroglioma | 5 | 2019 | 278 | 0.930 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 23 | 2025 | 11886 | 0.910 |
Why?
|
Carcinoma, Neuroendocrine | 2 | 2023 | 342 | 0.810 |
Why?
|
TOR Serine-Threonine Kinases | 6 | 2014 | 2063 | 0.800 |
Why?
|
Dacarbazine | 3 | 2013 | 559 | 0.750 |
Why?
|
Intestinal Neoplasms | 6 | 2023 | 314 | 0.750 |
Why?
|
Paraganglioma | 1 | 2022 | 143 | 0.720 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 5 | 2019 | 496 | 0.700 |
Why?
|
Pheochromocytoma | 1 | 2022 | 328 | 0.690 |
Why?
|
Octreotide | 6 | 2024 | 155 | 0.670 |
Why?
|
Chromosomes, Human, Pair 19 | 4 | 2013 | 350 | 0.610 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2019 | 314 | 0.600 |
Why?
|
Neural Stem Cells | 4 | 2021 | 895 | 0.570 |
Why?
|
Stomach Neoplasms | 6 | 2024 | 1483 | 0.570 |
Why?
|
Glioma | 14 | 2023 | 3532 | 0.560 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2022 | 735 | 0.550 |
Why?
|
Ependymoma | 4 | 2024 | 328 | 0.500 |
Why?
|
Glioblastoma | 13 | 2024 | 3525 | 0.480 |
Why?
|
Antineoplastic Agents | 9 | 2020 | 13698 | 0.470 |
Why?
|
Gene Expression Regulation, Neoplastic | 18 | 2023 | 8664 | 0.450 |
Why?
|
Repressor Proteins | 5 | 2022 | 2986 | 0.450 |
Why?
|
Esophageal Neoplasms | 4 | 2024 | 1674 | 0.450 |
Why?
|
Somatostatin | 5 | 2025 | 458 | 0.430 |
Why?
|
Colorectal Neoplasms | 14 | 2019 | 6982 | 0.420 |
Why?
|
Practice Guidelines as Topic | 5 | 2023 | 7460 | 0.420 |
Why?
|
Xenograft Model Antitumor Assays | 13 | 2020 | 3621 | 0.420 |
Why?
|
MicroRNAs | 8 | 2019 | 3811 | 0.410 |
Why?
|
Supratentorial Neoplasms | 1 | 2013 | 159 | 0.400 |
Why?
|
Carcinoid Tumor | 5 | 2020 | 224 | 0.380 |
Why?
|
Neoplastic Stem Cells | 6 | 2023 | 1356 | 0.380 |
Why?
|
Rhabdoid Tumor | 3 | 2020 | 211 | 0.380 |
Why?
|
Tumor Microenvironment | 6 | 2024 | 3952 | 0.370 |
Why?
|
Sirolimus | 7 | 2013 | 1540 | 0.360 |
Why?
|
Molecular Targeted Therapy | 5 | 2016 | 2830 | 0.360 |
Why?
|
Disease-Free Survival | 17 | 2022 | 6856 | 0.360 |
Why?
|
Teratoma | 3 | 2020 | 405 | 0.350 |
Why?
|
Isocitrate Dehydrogenase | 6 | 2015 | 958 | 0.350 |
Why?
|
Humans | 154 | 2025 | 768970 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2022 | 3518 | 0.330 |
Why?
|
Consensus | 5 | 2023 | 3214 | 0.320 |
Why?
|
Infratentorial Neoplasms | 3 | 2024 | 99 | 0.320 |
Why?
|
RNA-Binding Proteins | 3 | 2017 | 1891 | 0.320 |
Why?
|
Gene Amplification | 1 | 2013 | 1099 | 0.320 |
Why?
|
Astrocytoma | 3 | 2013 | 781 | 0.320 |
Why?
|
Oncolytic Viruses | 2 | 2024 | 345 | 0.310 |
Why?
|
Guanine | 1 | 2010 | 280 | 0.310 |
Why?
|
Molecular Imaging | 1 | 2015 | 826 | 0.310 |
Why?
|
Glutamates | 1 | 2010 | 385 | 0.310 |
Why?
|
Adenocarcinoma | 5 | 2024 | 6401 | 0.300 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2019 | 3612 | 0.300 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 4 | 2015 | 1143 | 0.290 |
Why?
|
Neoplasm Recurrence, Local | 8 | 2022 | 9442 | 0.280 |
Why?
|
Kaplan-Meier Estimate | 13 | 2020 | 6547 | 0.280 |
Why?
|
Nerve Tissue Proteins | 8 | 2019 | 4413 | 0.280 |
Why?
|
Oncolytic Virotherapy | 2 | 2024 | 521 | 0.280 |
Why?
|
Female | 86 | 2025 | 397515 | 0.280 |
Why?
|
Proteoglycans | 2 | 2009 | 809 | 0.270 |
Why?
|
Cell Line, Tumor | 22 | 2024 | 17173 | 0.260 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 647 | 0.260 |
Why?
|
Mutation | 20 | 2022 | 30266 | 0.260 |
Why?
|
Nuclear Medicine | 2 | 2020 | 262 | 0.250 |
Why?
|
Egg Proteins | 4 | 1996 | 58 | 0.250 |
Why?
|
Signal Transduction | 18 | 2021 | 23653 | 0.250 |
Why?
|
Organometallic Compounds | 2 | 2020 | 648 | 0.250 |
Why?
|
Male | 73 | 2025 | 365203 | 0.250 |
Why?
|
Tuberous Sclerosis | 4 | 2011 | 1042 | 0.250 |
Why?
|
Cell Proliferation | 16 | 2020 | 10486 | 0.250 |
Why?
|
Central Nervous System | 3 | 2014 | 1346 | 0.240 |
Why?
|
Oncogene Proteins, Fusion | 4 | 2022 | 1616 | 0.240 |
Why?
|
Cerebral Ventricle Neoplasms | 1 | 2004 | 43 | 0.240 |
Why?
|
Societies, Medical | 5 | 2020 | 3968 | 0.240 |
Why?
|
Cerebellum | 5 | 2022 | 1522 | 0.240 |
Why?
|
Otx Transcription Factors | 2 | 2022 | 42 | 0.230 |
Why?
|
Vestibular Diseases | 1 | 2006 | 232 | 0.220 |
Why?
|
Colonic Neoplasms | 3 | 2014 | 2543 | 0.220 |
Why?
|
Mitosis | 1 | 2009 | 1181 | 0.220 |
Why?
|
Lateral Ventricles | 1 | 2004 | 145 | 0.220 |
Why?
|
Mice | 39 | 2024 | 82072 | 0.220 |
Why?
|
North America | 3 | 2023 | 1290 | 0.220 |
Why?
|
Mice, SCID | 7 | 2020 | 2631 | 0.220 |
Why?
|
Metencephalon | 1 | 2022 | 3 | 0.210 |
Why?
|
ras Proteins | 3 | 2015 | 1058 | 0.210 |
Why?
|
DNA Methylation | 10 | 2019 | 4432 | 0.210 |
Why?
|
Consensus Development Conferences as Topic | 2 | 2020 | 169 | 0.210 |
Why?
|
Middle Aged | 46 | 2025 | 223737 | 0.200 |
Why?
|
Neurogenesis | 3 | 2021 | 865 | 0.200 |
Why?
|
Hypertension | 1 | 2022 | 8617 | 0.200 |
Why?
|
Antibodies, Monoclonal | 5 | 2012 | 9264 | 0.200 |
Why?
|
Gastrointestinal Neoplasms | 3 | 2023 | 957 | 0.190 |
Why?
|
Protein Kinases | 2 | 2008 | 1611 | 0.190 |
Why?
|
Tumor Cells, Cultured | 8 | 2020 | 6131 | 0.190 |
Why?
|
Contraception, Immunologic | 3 | 1996 | 5 | 0.190 |
Why?
|
Succinate Dehydrogenase | 1 | 2022 | 148 | 0.190 |
Why?
|
Aged | 37 | 2025 | 171786 | 0.190 |
Why?
|
Neurilemmoma | 1 | 2006 | 524 | 0.190 |
Why?
|
Radiation Genetics | 1 | 2020 | 16 | 0.190 |
Why?
|
Esophagogastric Junction | 2 | 2024 | 351 | 0.180 |
Why?
|
Neurons | 7 | 2019 | 9519 | 0.180 |
Why?
|
Alpha Particles | 1 | 2020 | 29 | 0.180 |
Why?
|
Adult | 40 | 2025 | 223851 | 0.180 |
Why?
|
Aged, 80 and over | 18 | 2025 | 59739 | 0.180 |
Why?
|
Chromosomes, Human, Pair 1 | 3 | 2012 | 640 | 0.180 |
Why?
|
Embryo, Mammalian | 3 | 2019 | 1676 | 0.180 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 5 | 2017 | 4592 | 0.180 |
Why?
|
Prognosis | 13 | 2021 | 30046 | 0.180 |
Why?
|
DNA Repair | 2 | 2020 | 2054 | 0.170 |
Why?
|
Protein Kinase Inhibitors | 3 | 2022 | 5707 | 0.170 |
Why?
|
Central Nervous System Neoplasms | 2 | 2020 | 930 | 0.170 |
Why?
|
Gene Expression Profiling | 13 | 2019 | 9549 | 0.170 |
Why?
|
Receptors, Somatostatin | 2 | 2018 | 138 | 0.170 |
Why?
|
DNA Copy Number Variations | 4 | 2018 | 2055 | 0.170 |
Why?
|
Estrogen Replacement Therapy | 1 | 2006 | 1209 | 0.170 |
Why?
|
Anus Neoplasms | 1 | 2024 | 336 | 0.170 |
Why?
|
DNA Damage | 2 | 2020 | 2472 | 0.170 |
Why?
|
Phenylurea Compounds | 2 | 2013 | 531 | 0.170 |
Why?
|
Animals | 42 | 2024 | 169335 | 0.170 |
Why?
|
RNA, Small Nuclear | 1 | 2019 | 71 | 0.160 |
Why?
|
Cell Differentiation | 7 | 2022 | 11684 | 0.160 |
Why?
|
Mesencephalon | 1 | 2021 | 339 | 0.160 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2021 | 458 | 0.160 |
Why?
|
In Situ Hybridization, Fluorescence | 5 | 2022 | 2525 | 0.160 |
Why?
|
Brain Stem Neoplasms | 2 | 2013 | 191 | 0.150 |
Why?
|
Receptors, Peptide | 1 | 2020 | 280 | 0.150 |
Why?
|
Tumor Suppressor Proteins | 4 | 2011 | 2812 | 0.150 |
Why?
|
Eligibility Determination | 1 | 2021 | 421 | 0.150 |
Why?
|
Genomics | 6 | 2023 | 5928 | 0.150 |
Why?
|
Pteridines | 1 | 2017 | 47 | 0.150 |
Why?
|
Genomic Structural Variation | 2 | 2022 | 80 | 0.140 |
Why?
|
Gene Knockdown Techniques | 2 | 2019 | 1608 | 0.140 |
Why?
|
Topotecan | 1 | 2017 | 131 | 0.140 |
Why?
|
Dactinomycin | 1 | 2017 | 305 | 0.140 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2020 | 5342 | 0.140 |
Why?
|
Chromosomes, Human, Pair 8 | 2 | 2009 | 453 | 0.140 |
Why?
|
Drug Delivery Systems | 2 | 2017 | 2238 | 0.140 |
Why?
|
Malignant Carcinoid Syndrome | 1 | 2017 | 31 | 0.140 |
Why?
|
MAP Kinase Signaling System | 2 | 2014 | 1495 | 0.140 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2018 | 200 | 0.140 |
Why?
|
Arsenicals | 1 | 2017 | 117 | 0.140 |
Why?
|
Neoplasm Metastasis | 6 | 2023 | 4926 | 0.140 |
Why?
|
Prosencephalon | 1 | 2019 | 306 | 0.140 |
Why?
|
Neoplasm Invasiveness | 2 | 2024 | 3629 | 0.140 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 423 | 0.140 |
Why?
|
Neoplasm Staging | 12 | 2019 | 11262 | 0.140 |
Why?
|
Vitamins | 2 | 2019 | 1638 | 0.140 |
Why?
|
STAT3 Transcription Factor | 3 | 2022 | 874 | 0.140 |
Why?
|
Survival Rate | 8 | 2020 | 12873 | 0.130 |
Why?
|
Nerve Degeneration | 1 | 2021 | 750 | 0.130 |
Why?
|
Child, Preschool | 17 | 2021 | 42683 | 0.130 |
Why?
|
Genomic Instability | 1 | 2020 | 715 | 0.130 |
Why?
|
Hospice Care | 1 | 2023 | 679 | 0.130 |
Why?
|
Diarrhea | 2 | 2020 | 1320 | 0.130 |
Why?
|
Apoptosis | 6 | 2020 | 9527 | 0.130 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2016 | 183 | 0.130 |
Why?
|
Bronchial Neoplasms | 1 | 2016 | 111 | 0.130 |
Why?
|
Treatment Outcome | 16 | 2024 | 65480 | 0.130 |
Why?
|
Receptors, Cell Surface | 4 | 1996 | 2820 | 0.130 |
Why?
|
Oxides | 1 | 2017 | 403 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 4 | 2013 | 4528 | 0.130 |
Why?
|
Cyclin D1 | 1 | 2017 | 453 | 0.130 |
Why?
|
Microsatellite Instability | 2 | 2010 | 726 | 0.120 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2017 | 2336 | 0.120 |
Why?
|
Oligopeptides | 1 | 2020 | 1194 | 0.120 |
Why?
|
Oligodendroglia | 1 | 2019 | 540 | 0.120 |
Why?
|
Receptor, trkC | 1 | 2014 | 63 | 0.120 |
Why?
|
Chromosomes, Human, Pair 10 | 2 | 2018 | 277 | 0.120 |
Why?
|
Vaccines, Synthetic | 3 | 1996 | 622 | 0.120 |
Why?
|
Drug Administration Schedule | 2 | 2013 | 4862 | 0.120 |
Why?
|
Blotting, Western | 4 | 2017 | 5033 | 0.120 |
Why?
|
Combined Modality Therapy | 4 | 2016 | 8559 | 0.120 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2017 | 354 | 0.120 |
Why?
|
Trans-Activators | 3 | 2013 | 2858 | 0.120 |
Why?
|
Oncogenes | 3 | 2020 | 1236 | 0.120 |
Why?
|
Proportional Hazards Models | 7 | 2020 | 12562 | 0.120 |
Why?
|
Membrane Glycoproteins | 4 | 1996 | 3713 | 0.120 |
Why?
|
Cell Division | 2 | 2021 | 4478 | 0.120 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2019 | 633 | 0.120 |
Why?
|
Triazoles | 1 | 2020 | 904 | 0.110 |
Why?
|
Child | 22 | 2024 | 80960 | 0.110 |
Why?
|
Receptor, trkB | 1 | 2014 | 124 | 0.110 |
Why?
|
Retinoblastoma Protein | 1 | 2017 | 673 | 0.110 |
Why?
|
Cholecalciferol | 1 | 2019 | 557 | 0.110 |
Why?
|
Single-Cell Analysis | 2 | 2023 | 2542 | 0.110 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2017 | 566 | 0.110 |
Why?
|
Dopamine | 1 | 2021 | 1596 | 0.110 |
Why?
|
Infant | 13 | 2024 | 36556 | 0.110 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2012 | 751 | 0.110 |
Why?
|
Receptor, erbB-2 | 1 | 2024 | 2606 | 0.110 |
Why?
|
Survival Analysis | 6 | 2020 | 10115 | 0.110 |
Why?
|
Gene Silencing | 2 | 2013 | 1505 | 0.110 |
Why?
|
Maximum Tolerated Dose | 2 | 2013 | 899 | 0.110 |
Why?
|
DNA Helicases | 1 | 2019 | 854 | 0.110 |
Why?
|
Glypicans | 1 | 2013 | 33 | 0.110 |
Why?
|
Mice, Inbred NOD | 2 | 2017 | 1839 | 0.110 |
Why?
|
Hypothalamic Neoplasms | 1 | 2013 | 21 | 0.110 |
Why?
|
Dendritic Cells | 1 | 2024 | 2748 | 0.110 |
Why?
|
Immunohistochemistry | 10 | 2017 | 11116 | 0.110 |
Why?
|
Hepatectomy | 1 | 2017 | 588 | 0.110 |
Why?
|
Benzimidazoles | 1 | 2018 | 864 | 0.110 |
Why?
|
Immunoenzyme Techniques | 2 | 2013 | 1705 | 0.100 |
Why?
|
Quinoxalines | 1 | 2015 | 297 | 0.100 |
Why?
|
Glutarates | 1 | 2014 | 243 | 0.100 |
Why?
|
L-Lactate Dehydrogenase | 1 | 2013 | 412 | 0.100 |
Why?
|
Autoantibodies | 3 | 2005 | 2120 | 0.100 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2014 | 319 | 0.100 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2022 | 1560 | 0.100 |
Why?
|
Nuclear Proteins | 3 | 2021 | 5804 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 264 | 0.100 |
Why?
|
Intestine, Small | 1 | 2018 | 1218 | 0.100 |
Why?
|
Wnt Proteins | 2 | 2014 | 725 | 0.100 |
Why?
|
Folic Acid | 2 | 2010 | 1338 | 0.100 |
Why?
|
Liver Neoplasms | 3 | 2017 | 4363 | 0.100 |
Why?
|
Genes, myc | 2 | 2012 | 391 | 0.100 |
Why?
|
Genes, Tumor Suppressor | 2 | 2008 | 1064 | 0.100 |
Why?
|
Cohort Studies | 15 | 2021 | 41808 | 0.100 |
Why?
|
Hypothalamic Diseases | 1 | 2013 | 134 | 0.100 |
Why?
|
Nerve Growth Factors | 1 | 2014 | 564 | 0.100 |
Why?
|
Papillomavirus Infections | 1 | 2024 | 1640 | 0.100 |
Why?
|
Retrospective Studies | 11 | 2024 | 81903 | 0.100 |
Why?
|
Fetus | 1 | 2019 | 1882 | 0.100 |
Why?
|
Germ-Line Mutation | 2 | 2018 | 1887 | 0.090 |
Why?
|
Vinblastine | 1 | 2013 | 487 | 0.090 |
Why?
|
Radiotherapy | 1 | 2018 | 1506 | 0.090 |
Why?
|
Stem Cells | 4 | 2015 | 3539 | 0.090 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1902 | 0.090 |
Why?
|
Receptor Protein-Tyrosine Kinases | 2 | 2023 | 1629 | 0.090 |
Why?
|
Bromodeoxyuridine | 2 | 2009 | 310 | 0.090 |
Why?
|
Astrocytes | 1 | 2019 | 1349 | 0.090 |
Why?
|
Young Adult | 13 | 2021 | 60131 | 0.090 |
Why?
|
Genes, ras | 1 | 2014 | 665 | 0.090 |
Why?
|
Oxidative Stress | 2 | 2020 | 3139 | 0.090 |
Why?
|
Prostatic Secretory Proteins | 1 | 2010 | 24 | 0.090 |
Why?
|
Prospective Studies | 12 | 2024 | 54962 | 0.090 |
Why?
|
Epigenomics | 1 | 2016 | 961 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4651 | 0.090 |
Why?
|
Niacinamide | 1 | 2013 | 418 | 0.090 |
Why?
|
Mice, Nude | 5 | 2020 | 3631 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 5 | 2018 | 18068 | 0.090 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 2893 | 0.090 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1894 | 0.090 |
Why?
|
Kruppel-Like Transcription Factors | 2 | 2014 | 507 | 0.090 |
Why?
|
Patient Selection | 2 | 2020 | 4265 | 0.090 |
Why?
|
Adolescent | 17 | 2021 | 89244 | 0.090 |
Why?
|
Receptors, CXCR4 | 2 | 2006 | 729 | 0.090 |
Why?
|
Nuclear Receptor Coactivators | 1 | 2010 | 62 | 0.090 |
Why?
|
Lymph Node Excision | 1 | 2016 | 1273 | 0.090 |
Why?
|
Insulin-Like Growth Factor Binding Protein 5 | 1 | 2010 | 28 | 0.090 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2012 | 414 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2015 | 751 | 0.090 |
Why?
|
In Situ Nick-End Labeling | 2 | 2009 | 612 | 0.090 |
Why?
|
Receptors, Prostaglandin E | 1 | 2010 | 56 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 2 | 2010 | 2059 | 0.090 |
Why?
|
Hydroxychloroquine | 1 | 2014 | 426 | 0.090 |
Why?
|
Up-Regulation | 1 | 2019 | 4148 | 0.080 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2022 | 637 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 627 | 0.080 |
Why?
|
Medical Oncology | 2 | 2023 | 2350 | 0.080 |
Why?
|
Carcinoma, Basal Cell | 1 | 2015 | 565 | 0.080 |
Why?
|
beta Catenin | 3 | 2010 | 1047 | 0.080 |
Why?
|
Survival | 1 | 2010 | 160 | 0.080 |
Why?
|
Chromatin | 2 | 2023 | 2981 | 0.080 |
Why?
|
Radiopharmaceuticals | 2 | 2009 | 2734 | 0.080 |
Why?
|
Oophoritis | 2 | 1996 | 4 | 0.080 |
Why?
|
Cell Cycle | 3 | 2020 | 2937 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2023 | 8055 | 0.080 |
Why?
|
Glycosylphosphatidylinositols | 1 | 2009 | 88 | 0.080 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2013 | 622 | 0.080 |
Why?
|
Cell Survival | 5 | 2019 | 5793 | 0.080 |
Why?
|
Meningeal Neoplasms | 1 | 2018 | 1258 | 0.080 |
Why?
|
DNA-Binding Proteins | 3 | 2019 | 9618 | 0.080 |
Why?
|
Endothelial Growth Factors | 1 | 2001 | 674 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2884 | 0.080 |
Why?
|
Telomerase | 1 | 2013 | 753 | 0.080 |
Why?
|
Neocortex | 1 | 2012 | 417 | 0.080 |
Why?
|
Somatomedins | 1 | 2008 | 179 | 0.080 |
Why?
|
Transcription, Genetic | 3 | 2019 | 7609 | 0.080 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 11932 | 0.080 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2024 | 4064 | 0.070 |
Why?
|
Models, Genetic | 1 | 2018 | 3449 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2014 | 998 | 0.070 |
Why?
|
Nitric Oxide Synthase | 1 | 2001 | 911 | 0.070 |
Why?
|
Lymphokines | 1 | 2001 | 927 | 0.070 |
Why?
|
MutS Homolog 2 Protein | 1 | 2008 | 200 | 0.070 |
Why?
|
Biliary Tract Neoplasms | 1 | 2009 | 187 | 0.070 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2015 | 1248 | 0.070 |
Why?
|
Ribosomal Protein S6 Kinases | 2 | 2004 | 203 | 0.070 |
Why?
|
Vitamin B Complex | 1 | 2010 | 299 | 0.070 |
Why?
|
Cerebral Cortex | 2 | 2014 | 5831 | 0.070 |
Why?
|
Quinolines | 1 | 2013 | 772 | 0.070 |
Why?
|
Chromosome Deletion | 1 | 2012 | 1390 | 0.070 |
Why?
|
Capillary Permeability | 1 | 2001 | 773 | 0.070 |
Why?
|
Phosphorylation | 5 | 2017 | 8317 | 0.070 |
Why?
|
Mice, Knockout | 3 | 2019 | 14484 | 0.070 |
Why?
|
Disease Progression | 4 | 2024 | 13674 | 0.070 |
Why?
|
Vitamin B 12 | 1 | 2010 | 529 | 0.070 |
Why?
|
Insulin | 2 | 2013 | 6610 | 0.070 |
Why?
|
Point Mutation | 1 | 2011 | 1596 | 0.070 |
Why?
|
Forecasting | 1 | 2015 | 2945 | 0.070 |
Why?
|
Pyrimidines | 2 | 2016 | 3048 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2017 | 9565 | 0.070 |
Why?
|
Zona Pellucida | 1 | 1996 | 15 | 0.070 |
Why?
|
Lymph Nodes | 2 | 2016 | 3473 | 0.070 |
Why?
|
Cell Culture Techniques | 1 | 2013 | 1667 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3450 | 0.060 |
Why?
|
Autophagy | 1 | 2014 | 1351 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2019 | 3443 | 0.060 |
Why?
|
Animals, Newborn | 2 | 2009 | 2683 | 0.060 |
Why?
|
Histones | 2 | 2023 | 2603 | 0.060 |
Why?
|
Ear Canal | 1 | 2006 | 149 | 0.060 |
Why?
|
Translocation, Genetic | 3 | 2022 | 1395 | 0.060 |
Why?
|
Genome, Human | 2 | 2024 | 4456 | 0.060 |
Why?
|
Research Design | 1 | 2021 | 6214 | 0.060 |
Why?
|
Tamoxifen | 1 | 2010 | 967 | 0.060 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2005 | 110 | 0.060 |
Why?
|
Sulfonamides | 1 | 2015 | 1981 | 0.060 |
Why?
|
CpG Islands | 1 | 2010 | 1210 | 0.060 |
Why?
|
Neoplasms | 4 | 2024 | 22389 | 0.060 |
Why?
|
Geriatric Assessment | 1 | 2013 | 1422 | 0.060 |
Why?
|
Leucovorin | 2 | 2019 | 643 | 0.060 |
Why?
|
Mice, Inbred C57BL | 7 | 2024 | 22379 | 0.060 |
Why?
|
DNA Mismatch Repair | 1 | 2008 | 432 | 0.060 |
Why?
|
Ribosomal Protein S6 | 1 | 2004 | 70 | 0.060 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2008 | 664 | 0.060 |
Why?
|
Genetic Testing | 1 | 2018 | 3591 | 0.060 |
Why?
|
Recurrence | 3 | 2019 | 8513 | 0.060 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 2024 | 93 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 2276 | 0.060 |
Why?
|
Tumor Burden | 3 | 2017 | 1913 | 0.060 |
Why?
|
Vesiculovirus | 1 | 2024 | 53 | 0.060 |
Why?
|
Rhabdomyoma | 1 | 2004 | 56 | 0.060 |
Why?
|
Liver Transplantation | 1 | 2017 | 2403 | 0.060 |
Why?
|
Cross-Priming | 1 | 2024 | 75 | 0.060 |
Why?
|
Mice, Mutant Strains | 2 | 2021 | 1755 | 0.060 |
Why?
|
Body Patterning | 1 | 2009 | 634 | 0.060 |
Why?
|
Ovarian Diseases | 1 | 1996 | 137 | 0.060 |
Why?
|
Pyrazoles | 1 | 2015 | 2029 | 0.060 |
Why?
|
Risk Factors | 12 | 2021 | 74976 | 0.060 |
Why?
|
Feasibility Studies | 2 | 2013 | 5323 | 0.060 |
Why?
|
Ovary | 2 | 1996 | 965 | 0.060 |
Why?
|
Population Surveillance | 1 | 2014 | 2597 | 0.060 |
Why?
|
Chemotherapy, Adjuvant | 4 | 2014 | 3554 | 0.060 |
Why?
|
Muscle Cells | 1 | 2004 | 195 | 0.060 |
Why?
|
Anilides | 2 | 2018 | 414 | 0.060 |
Why?
|
Alleles | 4 | 2013 | 6901 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2010 | 985 | 0.060 |
Why?
|
Neovascularization, Physiologic | 1 | 2001 | 1371 | 0.050 |
Why?
|
Autoimmune Diseases | 2 | 1996 | 2258 | 0.050 |
Why?
|
Organoplatinum Compounds | 2 | 2019 | 408 | 0.050 |
Why?
|
Data Collection | 1 | 2013 | 3324 | 0.050 |
Why?
|
Indoles | 2 | 2009 | 1836 | 0.050 |
Why?
|
Physical Exertion | 1 | 2006 | 668 | 0.050 |
Why?
|
Transcription Factors | 2 | 2022 | 12174 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2017 | 2780 | 0.050 |
Why?
|
Estradiol | 1 | 2010 | 1952 | 0.050 |
Why?
|
DNA Mutational Analysis | 3 | 2018 | 4124 | 0.050 |
Why?
|
Core Binding Factor alpha Subunits | 1 | 2022 | 25 | 0.050 |
Why?
|
Aspirin | 1 | 2014 | 3135 | 0.050 |
Why?
|
In Situ Hybridization | 3 | 2014 | 1904 | 0.050 |
Why?
|
Pyrroles | 1 | 2009 | 1125 | 0.050 |
Why?
|
Quality of Life | 2 | 2023 | 13510 | 0.050 |
Why?
|
Loss of Heterozygosity | 1 | 2004 | 663 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2005 | 563 | 0.050 |
Why?
|
Dexamethasone | 1 | 2010 | 1965 | 0.050 |
Why?
|
Promoter Regions, Genetic | 1 | 2013 | 5801 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2023 | 300 | 0.050 |
Why?
|
HEK293 Cells | 3 | 2019 | 4290 | 0.050 |
Why?
|
PTEN Phosphohydrolase | 1 | 2008 | 1120 | 0.050 |
Why?
|
Electroporation | 2 | 2014 | 238 | 0.050 |
Why?
|
Aging | 1 | 2021 | 8745 | 0.050 |
Why?
|
Fluorouracil | 2 | 2019 | 1655 | 0.050 |
Why?
|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2002 | 37 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2020 | 13021 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4672 | 0.050 |
Why?
|
Heparin | 1 | 2009 | 1636 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2011 | 2059 | 0.050 |
Why?
|
United States | 6 | 2023 | 73186 | 0.050 |
Why?
|
SEER Program | 2 | 2017 | 1473 | 0.050 |
Why?
|
Gene Expression | 2 | 2016 | 7603 | 0.050 |
Why?
|
Genetic Loci | 1 | 2010 | 2630 | 0.050 |
Why?
|
Radiography | 1 | 2012 | 6991 | 0.050 |
Why?
|
Heart Neoplasms | 1 | 2004 | 374 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2016 | 3810 | 0.050 |
Why?
|
Comparative Genomic Hybridization | 2 | 2013 | 474 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 4 | 2019 | 16053 | 0.050 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2009 | 2056 | 0.040 |
Why?
|
Multigene Family | 2 | 2014 | 1082 | 0.040 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 628 | 0.040 |
Why?
|
Cell Movement | 2 | 2018 | 5216 | 0.040 |
Why?
|
Formaldehyde | 2 | 2012 | 361 | 0.040 |
Why?
|
Immunoprecipitation | 2 | 2014 | 874 | 0.040 |
Why?
|
Protein Binding | 2 | 2009 | 9344 | 0.040 |
Why?
|
Lymphatic Metastasis | 2 | 2019 | 2916 | 0.040 |
Why?
|
Camptothecin | 2 | 2014 | 600 | 0.040 |
Why?
|
T-Box Domain Proteins | 1 | 2022 | 472 | 0.040 |
Why?
|
Histone Demethylases | 1 | 2022 | 328 | 0.040 |
Why?
|
Dyspepsia | 1 | 2020 | 116 | 0.040 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4207 | 0.040 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2019 | 108 | 0.040 |
Why?
|
Autoantigens | 1 | 1994 | 891 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2019 | 3433 | 0.040 |
Why?
|
Infertility, Female | 1 | 1995 | 764 | 0.040 |
Why?
|
Fibrinolytic Agents | 1 | 2009 | 2080 | 0.040 |
Why?
|
Microtubule-Associated Proteins | 2 | 2015 | 1074 | 0.040 |
Why?
|
Infertility | 1 | 1996 | 655 | 0.040 |
Why?
|
Disease Models, Animal | 3 | 2017 | 18354 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2017 | 2732 | 0.040 |
Why?
|
Paraffin Embedding | 2 | 2011 | 306 | 0.040 |
Why?
|
Immunity, Cellular | 2 | 2020 | 1560 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2013 | 12806 | 0.040 |
Why?
|
Gastritis | 1 | 2020 | 199 | 0.040 |
Why?
|
RNA Splice Sites | 1 | 2019 | 213 | 0.040 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2018 | 56 | 0.040 |
Why?
|
Consent Forms | 1 | 2018 | 55 | 0.040 |
Why?
|
Annexin A5 | 1 | 2018 | 104 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2018 | 15471 | 0.040 |
Why?
|
Parabiosis | 1 | 2018 | 65 | 0.040 |
Why?
|
Review Literature as Topic | 1 | 2020 | 298 | 0.040 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2023 | 620 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2019 | 428 | 0.040 |
Why?
|
Ribonuclease III | 1 | 2019 | 271 | 0.040 |
Why?
|
Heredity | 1 | 2018 | 149 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2911 | 0.040 |
Why?
|
Cytokines | 2 | 2024 | 7453 | 0.040 |
Why?
|
Mitotic Index | 1 | 2017 | 162 | 0.040 |
Why?
|
Postmenopause | 1 | 2006 | 2519 | 0.040 |
Why?
|
Chromatin Immunoprecipitation | 2 | 2012 | 859 | 0.040 |
Why?
|
Topoisomerase I Inhibitors | 1 | 2017 | 70 | 0.040 |
Why?
|
Transfection | 1 | 2005 | 5763 | 0.040 |
Why?
|
Hydroxyindoleacetic Acid | 1 | 2017 | 94 | 0.040 |
Why?
|
Prostatic Neoplasms | 2 | 2010 | 11230 | 0.030 |
Why?
|
Depression | 1 | 2017 | 8231 | 0.030 |
Why?
|
Muscle Proteins | 1 | 2022 | 1165 | 0.030 |
Why?
|
Flushing | 1 | 2017 | 52 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2023 | 3836 | 0.030 |
Why?
|
Lymphocyte Activation | 2 | 2024 | 5505 | 0.030 |
Why?
|
Membrane Proteins | 1 | 2013 | 7885 | 0.030 |
Why?
|
Macrophages | 2 | 2023 | 5801 | 0.030 |
Why?
|
Cell Nucleus | 2 | 2020 | 2885 | 0.030 |
Why?
|
DEAD-box RNA Helicases | 1 | 2019 | 385 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 3253 | 0.030 |
Why?
|
T-Lymphocytes | 4 | 2020 | 10276 | 0.030 |
Why?
|
Amino Acid Sequence | 5 | 2005 | 13427 | 0.030 |
Why?
|
Motor Activity | 1 | 2006 | 2713 | 0.030 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2002 | 617 | 0.030 |
Why?
|
Age Factors | 3 | 2018 | 18435 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2011 | 2848 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2010 | 10400 | 0.030 |
Why?
|
Chemokine CCL2 | 1 | 2018 | 606 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2018 | 755 | 0.030 |
Why?
|
H-2 Antigens | 2 | 1996 | 359 | 0.030 |
Why?
|
Molecular Sequence Data | 5 | 2005 | 17629 | 0.030 |
Why?
|
Mass Spectrometry | 2 | 2014 | 2204 | 0.030 |
Why?
|
Vaccines | 1 | 1994 | 843 | 0.030 |
Why?
|
Irritable Bowel Syndrome | 1 | 2020 | 454 | 0.030 |
Why?
|
Alberta | 1 | 2014 | 67 | 0.030 |
Why?
|
Proteins | 2 | 2012 | 6011 | 0.030 |
Why?
|
Pyridines | 2 | 2018 | 2895 | 0.030 |
Why?
|
RNA Splicing | 1 | 2019 | 905 | 0.030 |
Why?
|
Cells, Cultured | 4 | 2014 | 19023 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2226 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12095 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2019 | 12467 | 0.030 |
Why?
|
Odds Ratio | 3 | 2014 | 9684 | 0.030 |
Why?
|
Deoxycytidine | 2 | 2009 | 888 | 0.030 |
Why?
|
Lasers | 1 | 2019 | 952 | 0.030 |
Why?
|
HeLa Cells | 1 | 2020 | 3076 | 0.030 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 3 | 1 | 2015 | 109 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1105 | 0.030 |
Why?
|
Benzylamines | 2 | 2006 | 251 | 0.030 |
Why?
|
Heterocyclic Compounds | 2 | 2006 | 245 | 0.030 |
Why?
|
Retinoblastoma-Like Protein p130 | 1 | 2013 | 73 | 0.030 |
Why?
|
Pancreas | 1 | 2021 | 1700 | 0.030 |
Why?
|
Thromboplastin | 1 | 2015 | 288 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2017 | 682 | 0.030 |
Why?
|
Cytogenetics | 1 | 2014 | 198 | 0.030 |
Why?
|
Chromogranin A | 1 | 2013 | 47 | 0.030 |
Why?
|
Cell Lineage | 1 | 2022 | 2576 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2010 | 2018 | 0.030 |
Why?
|
Indazoles | 1 | 2015 | 306 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2014 | 286 | 0.030 |
Why?
|
Transforming Growth Factor beta | 2 | 2012 | 2004 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2009 | 6673 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 1996 | 1769 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 1769 | 0.030 |
Why?
|
Karnofsky Performance Status | 1 | 2013 | 167 | 0.030 |
Why?
|
Lymphoma | 1 | 2002 | 1900 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2017 | 910 | 0.030 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2014 | 411 | 0.030 |
Why?
|
Paraffin | 1 | 2012 | 36 | 0.030 |
Why?
|
Vertebrates | 1 | 2014 | 227 | 0.030 |
Why?
|
Helix-Loop-Helix Motifs | 1 | 2012 | 97 | 0.030 |
Why?
|
Disease Management | 1 | 2023 | 2537 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2018 | 3671 | 0.030 |
Why?
|
Gene Regulatory Networks | 1 | 2021 | 1752 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2014 | 551 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2015 | 664 | 0.020 |
Why?
|
Myocardium | 1 | 2004 | 4790 | 0.020 |
Why?
|
Genetic Heterogeneity | 1 | 2015 | 737 | 0.020 |
Why?
|
Chromatography, Gel | 1 | 2012 | 637 | 0.020 |
Why?
|
Sex Factors | 2 | 2016 | 10633 | 0.020 |
Why?
|
Microglia | 1 | 2020 | 1376 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1085 | 0.020 |
Why?
|
Magnetic Resonance Angiography | 1 | 2018 | 1434 | 0.020 |
Why?
|
COS Cells | 1 | 2013 | 1135 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2211 | 0.020 |
Why?
|
DNA, Neoplasm | 2 | 2009 | 1748 | 0.020 |
Why?
|
Gene Duplication | 1 | 2012 | 315 | 0.020 |
Why?
|
Half-Life | 1 | 2012 | 651 | 0.020 |
Why?
|
Hydroxyestrones | 1 | 2010 | 17 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2041 | 0.020 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2018 | 957 | 0.020 |
Why?
|
Ganglia, Spinal | 1 | 2014 | 530 | 0.020 |
Why?
|
Gene Fusion | 1 | 2013 | 357 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2149 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2011 | 6086 | 0.020 |
Why?
|
Dimerization | 1 | 2012 | 886 | 0.020 |
Why?
|
Canada | 1 | 2016 | 2130 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2474 | 0.020 |
Why?
|
Genotype | 2 | 2016 | 13048 | 0.020 |
Why?
|
Pedigree | 1 | 2018 | 4545 | 0.020 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 1 | 2010 | 48 | 0.020 |
Why?
|
Down-Regulation | 1 | 2017 | 2942 | 0.020 |
Why?
|
Blood Circulation | 1 | 2001 | 248 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7214 | 0.020 |
Why?
|
Saccharomyces cerevisiae | 1 | 2020 | 2682 | 0.020 |
Why?
|
Ear, Inner | 1 | 2014 | 426 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2010 | 21188 | 0.020 |
Why?
|
Exercise | 1 | 2006 | 5954 | 0.020 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2001 | 515 | 0.020 |
Why?
|
Isoenzymes | 1 | 2013 | 1687 | 0.020 |
Why?
|
TCF Transcription Factors | 1 | 2009 | 138 | 0.020 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2009 | 153 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2013 | 1714 | 0.020 |
Why?
|
Oncogene Protein v-akt | 1 | 2008 | 130 | 0.020 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39394 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 8 | 1 | 2008 | 49 | 0.020 |
Why?
|
Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2008 | 30 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2010 | 411 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2008 | 126 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2012 | 1524 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2011 | 2560 | 0.020 |
Why?
|
Palliative Care | 1 | 2023 | 3644 | 0.020 |
Why?
|
Cell Line | 1 | 2022 | 15604 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2018 | 20245 | 0.020 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2001 | 706 | 0.020 |
Why?
|
Risk | 2 | 2010 | 9621 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 208 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2018 | 3726 | 0.020 |
Why?
|
Tissue Fixation | 1 | 2008 | 245 | 0.020 |
Why?
|
Cyclooxygenase 2 | 1 | 2010 | 597 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2017 | 6512 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2460 | 0.020 |
Why?
|
Age of Onset | 1 | 2014 | 3346 | 0.020 |
Why?
|
Carmustine | 1 | 2006 | 137 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2019 | 10765 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 416 | 0.020 |
Why?
|
C-Peptide | 1 | 2008 | 443 | 0.020 |
Why?
|
Protons | 1 | 2012 | 1113 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4168 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2009 | 751 | 0.020 |
Why?
|
Phenotype | 2 | 2018 | 16731 | 0.020 |
Why?
|
Laminin | 1 | 2008 | 406 | 0.020 |
Why?
|
Time Factors | 3 | 2019 | 40261 | 0.020 |
Why?
|
Veratrum Alkaloids | 1 | 2005 | 23 | 0.020 |
Why?
|
Protein Structure, Tertiary | 1 | 2013 | 3775 | 0.020 |
Why?
|
Lymphocytes | 1 | 2014 | 2614 | 0.020 |
Why?
|
Risk Assessment | 3 | 2014 | 24333 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2010 | 1498 | 0.020 |
Why?
|
Litter Size | 1 | 1995 | 49 | 0.020 |
Why?
|
Fluoroimmunoassay | 1 | 2005 | 30 | 0.020 |
Why?
|
Mice, Inbred A | 1 | 1995 | 245 | 0.020 |
Why?
|
Genetic Variation | 1 | 2021 | 6611 | 0.020 |
Why?
|
Quinazolines | 1 | 2012 | 1373 | 0.020 |
Why?
|
Demyelinating Autoimmune Diseases, CNS | 1 | 2005 | 40 | 0.020 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3709 | 0.020 |
Why?
|
Binding Sites, Antibody | 1 | 2005 | 340 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2014 | 1520 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1996 | 300 | 0.010 |
Why?
|
DNA Primers | 1 | 2009 | 2827 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 2005 | 862 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6236 | 0.010 |
Why?
|
Phosphotransferases | 1 | 2005 | 302 | 0.010 |
Why?
|
Myosin Light Chains | 1 | 2004 | 122 | 0.010 |
Why?
|
Myelin Proteins | 1 | 2005 | 212 | 0.010 |
Why?
|
Solutions | 1 | 2005 | 410 | 0.010 |
Why?
|
Immunoblotting | 1 | 2008 | 1647 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2015 | 26428 | 0.010 |
Why?
|
Drosophila Proteins | 1 | 2014 | 1712 | 0.010 |
Why?
|
Oncogene Proteins | 1 | 2008 | 718 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2011 | 2635 | 0.010 |
Why?
|
Cardiac Myosins | 1 | 2004 | 128 | 0.010 |
Why?
|
Protein Processing, Post-Translational | 1 | 2012 | 1966 | 0.010 |
Why?
|
Glycogen | 1 | 2004 | 252 | 0.010 |
Why?
|
Gene Dosage | 1 | 2008 | 1222 | 0.010 |
Why?
|
Cell Adhesion | 1 | 2010 | 3102 | 0.010 |
Why?
|
NF-kappa B | 1 | 2012 | 2492 | 0.010 |
Why?
|
Piperidines | 1 | 2012 | 1667 | 0.010 |
Why?
|
Genome-Wide Association Study | 2 | 2016 | 12801 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1665 | 0.010 |
Why?
|
Retina | 1 | 2014 | 2661 | 0.010 |
Why?
|
Molecular Mimicry | 1 | 1994 | 213 | 0.010 |
Why?
|
Plasmids | 1 | 2008 | 2269 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2009 | 1369 | 0.010 |
Why?
|
Drug Synergism | 1 | 2006 | 1762 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2019 | 14794 | 0.010 |
Why?
|
Prostate | 1 | 2010 | 1781 | 0.010 |
Why?
|
Integrases | 1 | 2004 | 520 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2003 | 474 | 0.010 |
Why?
|
Sural Nerve | 1 | 2002 | 105 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2008 | 3438 | 0.010 |
Why?
|
Chemokines, CXC | 1 | 2003 | 420 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2013 | 4785 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2003 | 478 | 0.010 |
Why?
|
Nitric Oxide | 1 | 2001 | 2149 | 0.010 |
Why?
|
Luciferases | 1 | 2003 | 713 | 0.010 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2005 | 605 | 0.010 |
Why?
|
Chemokine CXCL12 | 1 | 2003 | 457 | 0.010 |
Why?
|
Cell Count | 1 | 2005 | 1833 | 0.010 |
Why?
|
Species Specificity | 1 | 1996 | 2417 | 0.010 |
Why?
|
Drug Combinations | 1 | 2008 | 2089 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2019 | 22296 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2001 | 2431 | 0.010 |
Why?
|
Immunization | 1 | 1995 | 1220 | 0.010 |
Why?
|
Pregnancy | 2 | 2014 | 30265 | 0.010 |
Why?
|
Prostatectomy | 1 | 2009 | 1841 | 0.010 |
Why?
|
Pandemics | 1 | 2021 | 8749 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2009 | 4625 | 0.010 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2008 | 1943 | 0.010 |
Why?
|
Brain | 2 | 2023 | 27453 | 0.010 |
Why?
|
Neural Conduction | 1 | 2002 | 443 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10868 | 0.010 |
Why?
|
Administration, Oral | 1 | 2008 | 4040 | 0.010 |
Why?
|
Chemotaxis | 1 | 2003 | 600 | 0.010 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1625 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2005 | 2067 | 0.010 |
Why?
|
RNA Interference | 1 | 2008 | 2835 | 0.010 |
Why?
|
Collagen | 1 | 2008 | 2646 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2960 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2003 | 2749 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2012 | 4939 | 0.010 |
Why?
|
Decision Making | 1 | 2013 | 3953 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1246 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2010 | 3702 | 0.010 |
Why?
|
Autoimmunity | 1 | 1995 | 1360 | 0.010 |
Why?
|
Databases, Factual | 1 | 2013 | 8094 | 0.010 |
Why?
|
Epitopes | 1 | 1994 | 2529 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 1995 | 3744 | 0.010 |
Why?
|
Nurses | 1 | 2006 | 2501 | 0.010 |
Why?
|
Models, Biological | 1 | 2011 | 9499 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2014 | 5892 | 0.010 |
Why?
|
Life Style | 1 | 2006 | 3931 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 2 | 2016 | 36854 | 0.010 |
Why?
|
Liver | 1 | 2008 | 7578 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2004 | 3840 | 0.010 |
Why?
|
Base Sequence | 1 | 2003 | 12430 | 0.010 |
Why?
|
Multiple Sclerosis | 1 | 2005 | 3250 | 0.010 |
Why?
|
Biopsy | 1 | 2002 | 6805 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20776 | 0.000 |
Why?
|
Anti-HIV Agents | 1 | 2003 | 4576 | 0.000 |
Why?
|